Orezone Reports Q2-2025 Production and Hard Rock Expansion Update 
Malaysia and France Strengthen Defence Industry Ties with Landmark MoU Signing InflaRx Appoints Dr. Camilla Chong as Chief Medical Officer
Camilla Chong, M.D., joins the team with 25 years of experience in the global pharmaceutical…
InflaRx Appoints Dr. Camilla Chong as Chief Medical Officer
Camilla Chong, M.D., joins the team with 25 years of experience in the global pharmaceutical…
First Wave BioPharma Announces Final Patient Dosed in Phase 2 SPAN Clinical Trial of Enhanced Adrulipase Formulation
Topline data expected in July 2023 BOCA RATON, Fla., June 28, 2023 (GLOBE NEWSWIRE) —…
First Wave BioPharma Announces Final Patient Dosed in Phase 2 SPAN Clinical Trial of Enhanced Adrulipase Formulation
Topline data expected in July 2023 BOCA RATON, Fla., June 28, 2023 (GLOBE NEWSWIRE) —…
Foghorn Therapeutics Announces Clinical Data from Phase 1 Study of FHD-286 in Metastatic Uveal Melanoma
– Clinical data support safety and tolerability profile of FHD-286, a highly potent, – selective,…
Foghorn Therapeutics Announces Clinical Data from Phase 1 Study of FHD-286 in Metastatic Uveal Melanoma
– Clinical data support safety and tolerability profile of FHD-286, a highly potent, – selective,…
Breckenridge Distillery Launches New Limited Release Collectors Art Series With Artist Sandra Fettingis
For its Third Annual Collectors Art Series, Breckenridge Distillery Partners with Local Colorado Artist to…
Breckenridge Distillery Launches New Limited Release Collectors Art Series With Artist Sandra Fettingis
For its Third Annual Collectors Art Series, Breckenridge Distillery Partners with Local Colorado Artist to…
Cognition Therapeutics Announces Positive Topline Results for CT1812 Phase 2 SEQUEL Study for Mild-to-Moderate Alzheimer’s Disease
Results Show Positive Treatment Effect of CT1812 on Global and Regional Brain Activity Management Holding…
Cognition Therapeutics Announces Positive Topline Results for CT1812 Phase 2 SEQUEL Study for Mild-to-Moderate Alzheimer’s Disease
Results Show Positive Treatment Effect of CT1812 on Global and Regional Brain Activity Management Holding…
Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2023, and Provides Business Update
RVT-3101 demonstrated improved efficacy results from the induction to chronic period in the TUSCANY-2 Phase…
Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2023, and Provides Business Update
RVT-3101 demonstrated improved efficacy results from the induction to chronic period in the TUSCANY-2 Phase…
Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol Injection
DEER PARK, Ill., June 28, 2023 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), an…
Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol Injection
DEER PARK, Ill., June 28, 2023 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), an…
Kineta Expands Board of Directors with Biotech Industry Leaders Kim Drapkin and Scott Dylla
SEATTLE, June 28, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company…
Kineta Expands Board of Directors with Biotech Industry Leaders Kim Drapkin and Scott Dylla
SEATTLE, June 28, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company…
Verizon upgrades network for Bonita Springs customers
Recent upgrades result in testing outcomes that show customers have the best experience on the…
Verizon upgrades network for Bonita Springs customers
Recent upgrades result in testing outcomes that show customers have the best experience on the…
Verizon upgrades network for Charleston customers
Recent upgrades result in testing outcomes that show customers have an outstanding experience on the…
data.world Announces Data Governance and Data Catalog Integrations with Snowflake’s Snowpark
The data catalog platform delivers catalog and governance capabilities for data-intensive applications AUSTIN, Texas, June…